Stock UTHR UNITED THERAPEUTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News United Therapeutics Corporation

Equities

UTHR

US91307C1027

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
275.1 USD +1.73% Intraday chart for United Therapeutics Corporation +0.82% +25.12%
May. 16 United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing MT
May. 14 United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Manufacturers Are "Winning" In The 340B Drug Discount Dispute
AQ
United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $582,195, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing
MT
UBS Adjusts Price Target on United Therapeutics to $300 From $290, Maintains Buy Rating
MT
Oppenheimer Adjusts United Therapeutics Price Target to $400 From $375, Maintains Outperform Rating
MT
Transcript : United Therapeutics Corporation, Q1 2024 Earnings Call, May 01, 2024
United Therapeutics Q1 Net Income, Revenue Advance; Shares Rise Pre-Bell
MT
Earnings Flash (UTHR) UNITED THERAPEUTICS CORPORATION Reports Q1 Revenue $677.7M, vs. Street Est of $624.2M
MT
United Therapeutics: Q1 Earnings Snapshot
AQ
Tranche Update on United Therapeutics Corporation's Equity Buyback Plan announced on March 25, 2024.
CI
United Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
BU
UNITED THERAPEUTICS ANNOUNCES WORLD'S FIRST SUCCESSFUL XENOTHYMOKIDNEY TRANSPLANT
AQ
CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. UTHR Stock
  4. News United Therapeutics Corporation